Stay updated on Lazertinib Combination in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.

Latest updates to the Lazertinib Combination in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous v3.4.1; no other content or navigation changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedA version tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedShow glossary is now available and metadata labels were added or renamed (Last Update Submitted that Met QC Criteria, Last Update Posted) along with a revision tag (v3.4.0). Core study data and functionality remain unchanged, to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label changed from v3.3.3 to v3.3.4. This is a minor metadata update and does not affect study details or user-facing content.SummaryDifference0.0%

- Check80 days agoChange DetectedMilestone dates on the study page have been updated: 2025-12-24, 2025-12-18, and 2028-03-27 were added, while 2025-12-04, 2025-12-05, and 2026-06-03 were removed.SummaryDifference0.1%

Stay in the know with updates to Lazertinib Combination in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.